SEC Form 4 · accession 0001209191-16-156658
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian G. Drazba
Officer — VP, Finance & CFO
Period of report
Apr 29, 2016
Accepted (ET)
Dec 23, 2016 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 29, 2016 | J | 577 | $18.224 | A | 3,260 | D | |
| Common Stock | Oct 31, 2016 | J | 538 | $12.6225 | A | 3,798 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan.